Cardiovascular Disease

Women with diabetes face higher risk of artery disease from hormones

Published in Obesity and Diabetes Week, July 19th, 2004

Postmenopausal hormone therapy can promote cardiovascular disease in women with diabetes or pre-diabetes (abnormal fasting glucose), study findings show.

While hormone therapy improved women's cholesterol, fasting glucose, and insulin resistance, it significantly worsened artery narrowing and exacerbated inflammatory markers, such as C-reactive protein (CRP) and fibrinogen, which are linked to cardiovascular disease.

The new study, reported in the June 29, 2004, rapid access issue of Circulation, is the first trial to use angiography, or X-rays of coronary vessels, to document the progression of atherosclerosis in postmenopausal women with...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week

Source: Obesity and Diabetes Week (2004-07-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry